(Reuters) – CVS Health Corp, best known for its national chain of drugstores, said on Thursday it had started offering clinical study services to support drug developers with
Timing could make a difference: new results suggest that patients with glioblastoma who took temozolomide (Temodar) in the morning rather than the evening showed an improved overall survival.
Cardiovascular disease was the leading cause of death among the over 16,000 patients with type 2 diabetes (T2DM) who were enrolled in the SAVOR-TIMI 53 trial. Two-thirds (66.3%)
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok